Chronic kidney disease (CKD) 
Introduction

Chronic kidney disease (CKD) is a new medical term developed to educate patients, family members of patients, non-nephrology physicians, and even nephrologists. The concept of CKD was developed to prevent end-stage renal disease (ESRD) and other related medical complications. Proteinuria is a known risk factor for cardiovascular disease (CVD) and mortality. CKD is now also widely accepted as a risk factor for CVD and mortality (1-3). Recent reports, including some from Japan, support this notion (4-6). In addition to the conventional risk factors for CVD, CKD is often associated with non-conventional risk factors such as anemia and serum calcium and phosphate disturbances, which are proportional to CKD stage (7-10). According to the Japanese Society for Dialysis Therapy (JSDT), since 2005 the incidence of patients with ESRD starting chronic dialysis therapy has been greater than 2,000 per million population. The survival rate of ESRD patients is poor and the main cause of death is CVD. The prevalence of ESRD is increasing despite several strategies, including universal screening and new drugs pharmaceutical intervention
. 
What is CKD?
CKD is defined as a syndrome of low glomerular filtration rate (GFR;<60 ml/min/1. 73 i g u r e 1 . P r e v a l e n c e o f c h r o n i c d i a l y s i s p a t i e n t s i n J a p a n ( Da t a a r e f r o m t h e J a p a n e s e S o c i e t y f o r Di a l y s i s T h e r a p y ) . Ab b r e v i a t i o n s : ACE I : a n g i o t e n s i n -c o n v e r t i n g e n z y me i n h i b i t o r , E S A: e r y t h r o p o i e s i s -s t i mu l a t i n g a g e n t , ARB : a n g i o t e n s i n r e c e p t o r b l o c k e r , J S N: J a p a n e s e S o c i e t y o f Ne p h r o l o g y T a b l e 1 . De mo g r a p h i c Ch a n g e s i n S c r e e n e e s i n Ok i n a wa .
B MI : Mo d y Ma s s I n d e x , S B P : S y s t o l i c B l o o d P r e s s u r e , T C: T o t a l Ch o l e s t e r o l , F P G: F a s t i n g P l a s ma Gl u c o s e . S e r u m Cr e a t i n i n e wa s Me a s u r e d Us i n g t h e Mo d i f i e d Ya f f e ' Me t h o d i n
1 9 8 3 a n d 1 9 9 3 , a n d E n z y me As s a y i n 2 0 0 3 . L o w GF R < 6 0 ml / mi n / 1 . 
ESRD Risk Factors
Lysaght estimated that there will be more than 2 million dialysis patients in the world by 2010, and approximately 0.3 million in Japan alone (16) (21) . The relationship between baseline BMI and the cumulative incidence of ESRD is linear, particularly in men (22, 23) , but a similar trend in both men and women has been reported (23) .
F i g u r e 2 . E f f e c t o f p r o t e i n u r i a a n d e s t i ma t e d c r e a t i n i n e c l e a r a n c e o n t h e c u mu l a t i v e i n c i d e n c e o f E S RD ( Re f 1 9 ) . Cc r : c r e a t i n i n e c l e a r a n c e
Predictors of CKD Stages 1 to 4
The (24) . Among the lifestyle-related factors, smoking is a known risk factor of CKD (25) . Smoking may accelerate kidney damage in patients with metabolic syndrome (25, 26) . Moderate alcohol intake, less than 20 g/day, decreases the risk of CKD (25) . Hyperuricemia is often associated with CKD, and is also a risk factor for developing CKD (27, 28) . Hyperuricemia per se induces an increase in blood pressure. A high fructose intake may raise the serum uric acid concentration (29) .
Obesity and metabolic syndrome are associated with the increased prevalence and incidence of CKD. Morbid obesity per se may cause idiopathic, rapidly progressive focal segmental glomerulosclerosis in individuals without primary renal disease (30) . The higher the BMI, the higher the incidence of proteinuria. In the community-based screened population, obese individuals have multiple risk factors for atherosclerosis (31) (32) (33) . The prevalence of CKD increases linearly with the number of components of metabolic syndrome (34, 35) . Metabolic syndrome is a significant predictor of developing CKD (Fig. 3) (36, 37) . The findings of Ejerblad et al (38) support the notion of a positive relation between BMI and renal failure.
There are multiple mechanisms of CKD among metabolic (43) . (Fig. 4) (51) 
Sleep apnea syndrome is often associated with obesity (44, 45). The disorder is widely associated with a high rate of morbidity and mortality, mostly due to CVD and traffic accidents (46, 47). Sleep apnea is also common in patients with ESRD (48, 49). Few studies, however, have examined the prevalence of apnea in patients with CKD who are not on dialysis (50).
CKD as a Risk Factor for CVD
CKD Screening
Early detection and treatment might decrease the incidence of ESRD. In this regard, Japan has a long history of universal screening (56) (60) . (61, 62) . There is a protective effect of weight loss on CKD progression prior to progression to ESRD, but weight reduction may no longer be indicated once a patient progresses to ESRD, as renal replacement therapy has a paradoxical effect on survival (63 (65) . In the case of sleep apnea, continuous positive airway pressure is effective for preventing CVD and maybe CKD (66, 67) . Appropriate hypoxia, however, such as that induced by high altitude, is good for humans
F i g u r e 4 . Cu mu l a t i v e i n c i d e n c e o f CVD a c c o r d i n g t o t h e p r e s e n c e o r a b s e n c e o f CKD ( Hi s a y a ma S t u d y , Re f 5 ) .
T a b l e 2 . S t r a t e g i e s f o r e a r l y d e t e c t i o n o f CKD ( Re f . 1 2 )
Treatment of CKD
Lifestyle modifications among those with metabolic syndrome are required. Weight reduction is effective for reducing proteinuria in obese patients
T a b l e 3 . T i mi n g o f Re f e r r a l t o Ne p h r o l o g i s t s ( CKD P r a c t i c e Gu i d e , www. j s n . o r . j p )
F i g u r e 5 . Co mp a r i s o n o f GF R b y a g e b e t we e n t h e US a n d Ok i n a wa . NHANE S I I I : T h e Na t i o n a l He a l t h a n d Nu t r i t i o n E x a mi n a t i o n S u r v e y s I I I , OGHMA: Ok i n a wa Ge n e r a l He a l t h Ma i n t e n a n c e As s o c i a t i o n .
F i g u r e 6 . Ch a n g e s i n CKD P r e v a l e n c e i n Hi s a y a ma ( Re f 7 4 ) . and can also naturally treat obesity (68) (73) . The prevalence of CKD seems to be increasing along with the increase in BMI, DM, and hypertension. Based on the eGFR, baseline GFR and the extent of an age-related GFR decline differ among ethnic groups (Fig. 5) . CKD is common in Japan and is expected to increase, particularly in the aging population. According to the Hisayama study, CKD prevalence is increasing in both men and women (Fig. 6) (74) . The reasons for this trend may be related to both genetic and environmental factors (Table 4) . Subjects with low birth weight, which is associated with a lower nephron number (75) , might develop insulin resistance and therefore have an increased risk of CKD (76, 77) . T a b l e 4 . J a p a n e s e a s a Hi g h Ri s k P o p u l a t i o n f o 
